Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies

A pooled data analysis of two double-blind studies encompassing 1137 episodes of community-acquired pneumonia in hospitalised adults, of which 560 were treated with sparfloxacin and 577 were randomised to comparator antibacterial agents (amoxycillin/clavulanic acid, erythromycin or amoxycillin admin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 1996-05, Vol.37 (suppl-A), p.73-82
Hauptverfasser:	Aubier, M., Lode, H., Gialdroni-Grassi, G., Huchon, G., Hosie, J., Legakis, N., Regamey, C., Segev, S., Vester, R., Wijnands, W. J., Tolstuchow, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Amoxicillin - therapeutic use Amoxicillin-Potassium Clavulanate Combination Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - therapeutic use Clavulanic Acids - therapeutic use Community-Acquired Infections - drug therapy Community-Acquired Infections - microbiology Double-Blind Method Drug Therapy, Combination - therapeutic use Erythromycin - therapeutic use Fluoroquinolones Humans Microbial Sensitivity Tests Penicillins - therapeutic use Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Quinolones - therapeutic use Streptococcus pneumoniae - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!